| 摘要 |
The present invention relates to compositions and methods to improve expression of exogenous polypeptides, such as an antigen, epitope, immunogen, peptide or polypeptide of interest, in viral vaccines. More particularly, the present invention provides for viral vaccines with increased adjuvantation via a genetic adjuvant. |
